TGFB1 and melanoma: The involvement of the TGF-β/SMAD pathway in melanoma progression could be potentially important in OSA patients, since previous studies have shown that increased hypoxia-induced factor (HIF) secondary to hypoxia induces the activation of the TGF-β1/SMAD signaling pathway17–19.